other material
confidence high
sentiment neutral
materiality 0.60
ZyVersa raises ~$830k via warrant inducement at $3.46; issues 200% new warrants
ZyVersa Therapeutics, Inc.
- Holder exercises existing Series A/B warrants at reduced price $3.46 (from $12.50), gross proceeds ~$830k.
- New Series A-1 warrants for 392k shares (5-yr term) and Series B-1 for 86.6k shares (18-mo term), all at $3.46.
- New warrant shares subject to stockholder approval; meeting to be held within 90 days of closing.
- Engaged A.G.P./Alliance Global Partners as financial advisor for $50k cash fee.
- Company to file resale registration statement for new warrant shares by September 2, 2024.